nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—UGT2B7—Epirubicin—liver cancer	0.369	0.722	CbGbCtD
Silodosin—ABCB4—bile canaliculus—liver cancer	0.175	0.602	CbGeAlD
Silodosin—ABCB1—Sorafenib—liver cancer	0.0554	0.108	CbGbCtD
Silodosin—ABCB4—bile duct—liver cancer	0.0548	0.188	CbGeAlD
Silodosin—ABCB4—bile—liver cancer	0.0421	0.144	CbGeAlD
Silodosin—ABCB1—Doxorubicin—liver cancer	0.0336	0.0657	CbGbCtD
Silodosin—CYP3A4—Sorafenib—liver cancer	0.0332	0.0649	CbGbCtD
Silodosin—CYP3A4—Doxorubicin—liver cancer	0.0201	0.0394	CbGbCtD
Silodosin—ABCB4—gall bladder—liver cancer	0.0117	0.0401	CbGeAlD
Silodosin—ABCB4—liver—liver cancer	0.00343	0.0118	CbGeAlD
Silodosin—Rhinorrhoea—Sorafenib—liver cancer	0.00206	0.051	CcSEcCtD
Silodosin—UGT2B7—liver—liver cancer	0.00175	0.00602	CbGeAlD
Silodosin—Hepatic function abnormal—Sorafenib—liver cancer	0.00139	0.0343	CcSEcCtD
Silodosin—Breast disorder—Sorafenib—liver cancer	0.00109	0.0271	CcSEcCtD
Silodosin—Nasopharyngitis—Sorafenib—liver cancer	0.00108	0.0268	CcSEcCtD
Silodosin—Erectile dysfunction—Sorafenib—liver cancer	0.000965	0.0239	CcSEcCtD
Silodosin—Jaundice—Sorafenib—liver cancer	0.00091	0.0225	CcSEcCtD
Silodosin—Hepatobiliary disease—Sorafenib—liver cancer	0.000883	0.0219	CcSEcCtD
Silodosin—ADRA1A—liver—liver cancer	0.000799	0.00274	CbGeAlD
Silodosin—Cardiac disorder—Sorafenib—liver cancer	0.000778	0.0193	CcSEcCtD
Silodosin—Angiopathy—Sorafenib—liver cancer	0.000761	0.0188	CcSEcCtD
Silodosin—Immune system disorder—Sorafenib—liver cancer	0.000757	0.0188	CcSEcCtD
Silodosin—Mediastinal disorder—Sorafenib—liver cancer	0.000755	0.0187	CcSEcCtD
Silodosin—Mental disorder—Sorafenib—liver cancer	0.000734	0.0182	CcSEcCtD
Silodosin—ABCB1—embryo—liver cancer	0.000732	0.00251	CbGeAlD
Silodosin—Syncope—Sorafenib—liver cancer	0.000654	0.0162	CcSEcCtD
Silodosin—Loss of consciousness—Sorafenib—liver cancer	0.000641	0.0159	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000617	0.0153	CcSEcCtD
Silodosin—Dry mouth—Sorafenib—liver cancer	0.000608	0.015	CcSEcCtD
Silodosin—Shock—Sorafenib—liver cancer	0.000586	0.0145	CcSEcCtD
Silodosin—Nervous system disorder—Sorafenib—liver cancer	0.000584	0.0145	CcSEcCtD
Silodosin—Skin disorder—Sorafenib—liver cancer	0.000578	0.0143	CcSEcCtD
Silodosin—Gastrointestinal disorder—Sorafenib—liver cancer	0.000514	0.0127	CcSEcCtD
Silodosin—Hepatic function abnormal—Epirubicin—liver cancer	0.000512	0.0127	CcSEcCtD
Silodosin—Vascular purpura—Epirubicin—liver cancer	0.000501	0.0124	CcSEcCtD
Silodosin—Gastrointestinal pain—Sorafenib—liver cancer	0.000487	0.0121	CcSEcCtD
Silodosin—CYP3A4—liver—liver cancer	0.000478	0.00164	CbGeAlD
Silodosin—Hepatic function abnormal—Doxorubicin—liver cancer	0.000474	0.0117	CcSEcCtD
Silodosin—Urticaria—Sorafenib—liver cancer	0.000473	0.0117	CcSEcCtD
Silodosin—Abdominal pain—Sorafenib—liver cancer	0.000471	0.0117	CcSEcCtD
Silodosin—Purpura—Epirubicin—liver cancer	0.000465	0.0115	CcSEcCtD
Silodosin—Vascular purpura—Doxorubicin—liver cancer	0.000463	0.0115	CcSEcCtD
Silodosin—Purpura—Doxorubicin—liver cancer	0.00043	0.0106	CcSEcCtD
Silodosin—Asthenia—Sorafenib—liver cancer	0.000427	0.0106	CcSEcCtD
Silodosin—Pruritus—Sorafenib—liver cancer	0.000421	0.0104	CcSEcCtD
Silodosin—Liver function test abnormal—Epirubicin—liver cancer	0.000413	0.0102	CcSEcCtD
Silodosin—Orthostatic hypotension—Epirubicin—liver cancer	0.000409	0.0101	CcSEcCtD
Silodosin—Diarrhoea—Sorafenib—liver cancer	0.000407	0.0101	CcSEcCtD
Silodosin—Breast disorder—Epirubicin—liver cancer	0.000405	0.01	CcSEcCtD
Silodosin—Nasopharyngitis—Epirubicin—liver cancer	0.0004	0.00992	CcSEcCtD
Silodosin—Dizziness—Sorafenib—liver cancer	0.000394	0.00975	CcSEcCtD
Silodosin—Liver function test abnormal—Doxorubicin—liver cancer	0.000383	0.00947	CcSEcCtD
Silodosin—Orthostatic hypotension—Doxorubicin—liver cancer	0.000378	0.00937	CcSEcCtD
Silodosin—Rash—Sorafenib—liver cancer	0.000376	0.0093	CcSEcCtD
Silodosin—Dermatitis—Sorafenib—liver cancer	0.000375	0.00929	CcSEcCtD
Silodosin—Breast disorder—Doxorubicin—liver cancer	0.000374	0.00927	CcSEcCtD
Silodosin—Headache—Sorafenib—liver cancer	0.000373	0.00924	CcSEcCtD
Silodosin—Nasopharyngitis—Doxorubicin—liver cancer	0.000371	0.00918	CcSEcCtD
Silodosin—Nausea—Sorafenib—liver cancer	0.000354	0.00876	CcSEcCtD
Silodosin—ABCB1—liver—liver cancer	0.000338	0.00116	CbGeAlD
Silodosin—Jaundice—Epirubicin—liver cancer	0.000336	0.00833	CcSEcCtD
Silodosin—Hepatobiliary disease—Epirubicin—liver cancer	0.000326	0.00808	CcSEcCtD
Silodosin—Sinusitis—Epirubicin—liver cancer	0.000324	0.00802	CcSEcCtD
Silodosin—Jaundice—Doxorubicin—liver cancer	0.000311	0.00771	CcSEcCtD
Silodosin—Hepatobiliary disease—Doxorubicin—liver cancer	0.000302	0.00748	CcSEcCtD
Silodosin—Sinusitis—Doxorubicin—liver cancer	0.0003	0.00742	CcSEcCtD
Silodosin—Cardiac disorder—Epirubicin—liver cancer	0.000288	0.00712	CcSEcCtD
Silodosin—Angiopathy—Epirubicin—liver cancer	0.000281	0.00696	CcSEcCtD
Silodosin—Immune system disorder—Epirubicin—liver cancer	0.00028	0.00693	CcSEcCtD
Silodosin—Mediastinal disorder—Epirubicin—liver cancer	0.000279	0.00692	CcSEcCtD
Silodosin—Mental disorder—Epirubicin—liver cancer	0.000271	0.00672	CcSEcCtD
Silodosin—Cardiac disorder—Doxorubicin—liver cancer	0.000266	0.00659	CcSEcCtD
Silodosin—Angiopathy—Doxorubicin—liver cancer	0.00026	0.00644	CcSEcCtD
Silodosin—Immune system disorder—Doxorubicin—liver cancer	0.000259	0.00641	CcSEcCtD
Silodosin—Mediastinal disorder—Doxorubicin—liver cancer	0.000258	0.0064	CcSEcCtD
Silodosin—Mental disorder—Doxorubicin—liver cancer	0.000251	0.00622	CcSEcCtD
Silodosin—Syncope—Epirubicin—liver cancer	0.000242	0.00599	CcSEcCtD
Silodosin—Palpitations—Epirubicin—liver cancer	0.000238	0.0059	CcSEcCtD
Silodosin—Loss of consciousness—Epirubicin—liver cancer	0.000237	0.00587	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000228	0.00565	CcSEcCtD
Silodosin—Dry mouth—Epirubicin—liver cancer	0.000225	0.00556	CcSEcCtD
Silodosin—Syncope—Doxorubicin—liver cancer	0.000224	0.00554	CcSEcCtD
Silodosin—Palpitations—Doxorubicin—liver cancer	0.000221	0.00546	CcSEcCtD
Silodosin—Loss of consciousness—Doxorubicin—liver cancer	0.000219	0.00543	CcSEcCtD
Silodosin—Shock—Epirubicin—liver cancer	0.000217	0.00536	CcSEcCtD
Silodosin—Nervous system disorder—Epirubicin—liver cancer	0.000216	0.00535	CcSEcCtD
Silodosin—Tachycardia—Epirubicin—liver cancer	0.000215	0.00532	CcSEcCtD
Silodosin—Skin disorder—Epirubicin—liver cancer	0.000214	0.00529	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000211	0.00523	CcSEcCtD
Silodosin—Dry mouth—Doxorubicin—liver cancer	0.000208	0.00515	CcSEcCtD
Silodosin—Hypotension—Epirubicin—liver cancer	0.000206	0.00509	CcSEcCtD
Silodosin—Shock—Doxorubicin—liver cancer	0.0002	0.00496	CcSEcCtD
Silodosin—Nervous system disorder—Doxorubicin—liver cancer	0.0002	0.00495	CcSEcCtD
Silodosin—Insomnia—Epirubicin—liver cancer	0.000199	0.00493	CcSEcCtD
Silodosin—Tachycardia—Doxorubicin—liver cancer	0.000199	0.00492	CcSEcCtD
Silodosin—Skin disorder—Doxorubicin—liver cancer	0.000198	0.0049	CcSEcCtD
Silodosin—Hypotension—Doxorubicin—liver cancer	0.00019	0.00471	CcSEcCtD
Silodosin—Gastrointestinal disorder—Epirubicin—liver cancer	0.00019	0.00471	CcSEcCtD
Silodosin—Insomnia—Doxorubicin—liver cancer	0.000184	0.00456	CcSEcCtD
Silodosin—Gastrointestinal pain—Epirubicin—liver cancer	0.00018	0.00446	CcSEcCtD
Silodosin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000176	0.00435	CcSEcCtD
Silodosin—Urticaria—Epirubicin—liver cancer	0.000175	0.00433	CcSEcCtD
Silodosin—Abdominal pain—Epirubicin—liver cancer	0.000174	0.00431	CcSEcCtD
Silodosin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000167	0.00412	CcSEcCtD
Silodosin—Urticaria—Doxorubicin—liver cancer	0.000162	0.00401	CcSEcCtD
Silodosin—Abdominal pain—Doxorubicin—liver cancer	0.000161	0.00399	CcSEcCtD
Silodosin—Asthenia—Epirubicin—liver cancer	0.000158	0.00391	CcSEcCtD
Silodosin—Pruritus—Epirubicin—liver cancer	0.000156	0.00386	CcSEcCtD
Silodosin—Diarrhoea—Epirubicin—liver cancer	0.000151	0.00373	CcSEcCtD
Silodosin—Asthenia—Doxorubicin—liver cancer	0.000146	0.00362	CcSEcCtD
Silodosin—Dizziness—Epirubicin—liver cancer	0.000146	0.0036	CcSEcCtD
Silodosin—Pruritus—Doxorubicin—liver cancer	0.000144	0.00357	CcSEcCtD
Silodosin—Diarrhoea—Doxorubicin—liver cancer	0.000139	0.00345	CcSEcCtD
Silodosin—Rash—Epirubicin—liver cancer	0.000139	0.00344	CcSEcCtD
Silodosin—Dermatitis—Epirubicin—liver cancer	0.000139	0.00343	CcSEcCtD
Silodosin—Headache—Epirubicin—liver cancer	0.000138	0.00341	CcSEcCtD
Silodosin—Dizziness—Doxorubicin—liver cancer	0.000135	0.00334	CcSEcCtD
Silodosin—Nausea—Epirubicin—liver cancer	0.000131	0.00324	CcSEcCtD
Silodosin—Rash—Doxorubicin—liver cancer	0.000128	0.00318	CcSEcCtD
Silodosin—Dermatitis—Doxorubicin—liver cancer	0.000128	0.00318	CcSEcCtD
Silodosin—Headache—Doxorubicin—liver cancer	0.000128	0.00316	CcSEcCtD
Silodosin—Nausea—Doxorubicin—liver cancer	0.000121	0.003	CcSEcCtD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.65e-05	0.000232	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTA3—liver cancer	3.64e-05	0.000232	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—MTHFR—liver cancer	3.62e-05	0.000231	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	3.57e-05	0.000227	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PPARA—liver cancer	3.56e-05	0.000226	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—F2—liver cancer	3.54e-05	0.000226	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.5e-05	0.000223	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TAT—liver cancer	3.48e-05	0.000221	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADAM17—liver cancer	3.44e-05	0.000219	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CG—liver cancer	3.39e-05	0.000216	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—AKT1—liver cancer	3.37e-05	0.000214	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.36e-05	0.000214	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.35e-05	0.000213	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CSF2—liver cancer	3.33e-05	0.000212	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTA4—liver cancer	3.33e-05	0.000212	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CD—liver cancer	3.28e-05	0.000209	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTA2—liver cancer	3.24e-05	0.000206	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—F2—liver cancer	3.24e-05	0.000206	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PSMA4—liver cancer	3.23e-05	0.000206	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PSMD10—liver cancer	3.23e-05	0.000206	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTA1—liver cancer	3.13e-05	0.000199	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.13e-05	0.000199	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.1e-05	0.000197	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CG—liver cancer	3.1e-05	0.000197	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NAT2—liver cancer	3.1e-05	0.000197	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADAM17—liver cancer	3.05e-05	0.000194	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CG—liver cancer	3.05e-05	0.000194	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PRKCE—liver cancer	3.02e-05	0.000192	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CD—liver cancer	2.98e-05	0.00019	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALDOB—liver cancer	2.97e-05	0.000189	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—F2—liver cancer	2.94e-05	0.000187	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PPARG—liver cancer	2.94e-05	0.000187	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—F2—liver cancer	2.88e-05	0.000183	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PSMA4—liver cancer	2.87e-05	0.000183	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PSMD10—liver cancer	2.87e-05	0.000183	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CB—liver cancer	2.86e-05	0.000182	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IGF2—liver cancer	2.86e-05	0.000182	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.85e-05	0.000181	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CRABP1—liver cancer	2.83e-05	0.00018	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.83e-05	0.00018	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CG—liver cancer	2.82e-05	0.000179	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.76e-05	0.000176	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CG—liver cancer	2.75e-05	0.000175	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CD—liver cancer	2.73e-05	0.000173	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CD—liver cancer	2.68e-05	0.00017	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CSF2—liver cancer	2.67e-05	0.00017	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—RAF1—liver cancer	2.66e-05	0.000169	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ALB—liver cancer	2.64e-05	0.000168	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—H2AFX—liver cancer	2.63e-05	0.000167	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—IL2—liver cancer	2.63e-05	0.000167	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—F2—liver cancer	2.61e-05	0.000166	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CB—liver cancer	2.6e-05	0.000165	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PRKCE—liver cancer	2.5e-05	0.000159	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CG—liver cancer	2.5e-05	0.000159	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CD—liver cancer	2.48e-05	0.000157	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HPGDS—liver cancer	2.47e-05	0.000157	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CD—liver cancer	2.42e-05	0.000154	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL2—liver cancer	2.39e-05	0.000152	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TERT—liver cancer	2.38e-05	0.000151	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CB—liver cancer	2.38e-05	0.000151	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF2—liver cancer	2.37e-05	0.000151	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CPT1B—liver cancer	2.37e-05	0.000151	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GLUL—liver cancer	2.37e-05	0.000151	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CB—liver cancer	2.33e-05	0.000148	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.33e-05	0.000148	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NR1H4—liver cancer	2.28e-05	0.000145	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTA3—liver cancer	2.24e-05	0.000143	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PRKCE—liver cancer	2.22e-05	0.000142	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CSF2—liver cancer	2.21e-05	0.000141	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—RAF1—liver cancer	2.21e-05	0.000141	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PSMD10—liver cancer	2.21e-05	0.00014	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PSMA4—liver cancer	2.21e-05	0.00014	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CD—liver cancer	2.2e-05	0.00014	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—H2AFX—liver cancer	2.18e-05	0.000139	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—IL2—liver cancer	2.18e-05	0.000139	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KDR—liver cancer	2.18e-05	0.000138	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK14—liver cancer	2.16e-05	0.000138	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CB—liver cancer	2.16e-05	0.000137	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GOT2—liver cancer	2.15e-05	0.000137	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ESR1—liver cancer	2.12e-05	0.000135	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CB—liver cancer	2.11e-05	0.000134	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF2—liver cancer	2.11e-05	0.000134	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.1e-05	0.000134	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—F2—liver cancer	2.09e-05	0.000133	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTA4—liver cancer	2.05e-05	0.000131	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP2E1—liver cancer	2.02e-05	0.000128	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CG—liver cancer	2e-05	0.000128	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APC—liver cancer	2e-05	0.000128	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTA2—liver cancer	2e-05	0.000127	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL2—liver cancer	1.98e-05	0.000126	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TERT—liver cancer	1.97e-05	0.000126	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CSF2—liver cancer	1.97e-05	0.000125	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—RAF1—liver cancer	1.96e-05	0.000125	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—H2AFX—liver cancer	1.94e-05	0.000123	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—IL2—liver cancer	1.94e-05	0.000123	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTA1—liver cancer	1.93e-05	0.000123	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CB—liver cancer	1.92e-05	0.000122	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NAT2—liver cancer	1.91e-05	0.000121	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.9e-05	0.000121	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYCS—liver cancer	1.89e-05	0.00012	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—BRAF—liver cancer	1.88e-05	0.00012	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GOT1—liver cancer	1.85e-05	0.000118	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GGT1—liver cancer	1.85e-05	0.000118	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALDOB—liver cancer	1.83e-05	0.000116	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KDR—liver cancer	1.81e-05	0.000115	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK14—liver cancer	1.79e-05	0.000114	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CD—liver cancer	1.76e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL2—liver cancer	1.76e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ESR1—liver cancer	1.76e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TERT—liver cancer	1.75e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CA—liver cancer	1.75e-05	0.000111	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CRABP1—liver cancer	1.74e-05	0.000111	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SERPINE1—liver cancer	1.74e-05	0.000111	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—F2—liver cancer	1.74e-05	0.000111	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—KRAS—liver cancer	1.72e-05	0.00011	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTP1—liver cancer	1.66e-05	0.000106	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CG—liver cancer	1.66e-05	0.000106	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APC—liver cancer	1.66e-05	0.000106	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMOX1—liver cancer	1.64e-05	0.000104	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KDR—liver cancer	1.6e-05	0.000102	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK14—liver cancer	1.59e-05	0.000101	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CA—liver cancer	1.58e-05	0.000101	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RAF1—liver cancer	1.57e-05	0.0001	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—BRAF—liver cancer	1.56e-05	9.95e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ESR1—liver cancer	1.56e-05	9.94e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—F2—liver cancer	1.54e-05	9.82e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CB—liver cancer	1.54e-05	9.77e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MTOR—liver cancer	1.54e-05	9.77e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTM1—liver cancer	1.53e-05	9.73e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HPGDS—liver cancer	1.52e-05	9.7e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APC—liver cancer	1.48e-05	9.4e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CG—liver cancer	1.48e-05	9.4e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HRAS—liver cancer	1.47e-05	9.33e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CD—liver cancer	1.46e-05	9.3e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP1A1—liver cancer	1.45e-05	9.22e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CA—liver cancer	1.45e-05	9.22e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SERPINE1—liver cancer	1.45e-05	9.2e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CDKN1B—liver cancer	1.44e-05	9.17e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—KRAS—liver cancer	1.43e-05	9.11e-05	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—AKT1—liver cancer	1.43e-05	9.07e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CA—liver cancer	1.42e-05	9.05e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CASP3—liver cancer	1.41e-05	8.99e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL2—liver cancer	1.41e-05	8.97e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL6—liver cancer	1.4e-05	8.93e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—BRAF—liver cancer	1.39e-05	8.84e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCND1—liver cancer	1.37e-05	8.75e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—JUN—liver cancer	1.37e-05	8.73e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CTNNB1—liver cancer	1.36e-05	8.66e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PSMA4—liver cancer	1.36e-05	8.65e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PSMD10—liver cancer	1.36e-05	8.65e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MTHFR—liver cancer	1.35e-05	8.6e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MMP9—liver cancer	1.33e-05	8.49e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CDKN1A—liver cancer	1.33e-05	8.46e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARA—liver cancer	1.33e-05	8.43e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GOT2—liver cancer	1.32e-05	8.41e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CA—liver cancer	1.32e-05	8.37e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RAF1—liver cancer	1.31e-05	8.31e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CD—liver cancer	1.3e-05	8.26e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK8—liver cancer	1.3e-05	8.26e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AKT1—liver cancer	1.29e-05	8.24e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CA—liver cancer	1.29e-05	8.19e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SERPINE1—liver cancer	1.28e-05	8.17e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CB—liver cancer	1.27e-05	8.11e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MTOR—liver cancer	1.27e-05	8.11e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—KRAS—liver cancer	1.27e-05	8.09e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP2E1—liver cancer	1.24e-05	7.91e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HRAS—liver cancer	1.22e-05	7.74e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—liver cancer	1.2e-05	7.63e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CDKN1B—liver cancer	1.2e-05	7.61e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—STAT3—liver cancer	1.19e-05	7.55e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AKT1—liver cancer	1.18e-05	7.53e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CASP3—liver cancer	1.17e-05	7.46e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL2—liver cancer	1.17e-05	7.45e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CA—liver cancer	1.17e-05	7.43e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6—liver cancer	1.16e-05	7.41e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYCS—liver cancer	1.16e-05	7.4e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AKT1—liver cancer	1.16e-05	7.39e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RAF1—liver cancer	1.16e-05	7.38e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GOT1—liver cancer	1.14e-05	7.26e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GGT1—liver cancer	1.14e-05	7.26e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCND1—liver cancer	1.14e-05	7.26e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—JUN—liver cancer	1.14e-05	7.25e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CG—liver cancer	1.14e-05	7.22e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MTOR—liver cancer	1.13e-05	7.2e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CB—liver cancer	1.13e-05	7.2e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CTNNB1—liver cancer	1.13e-05	7.19e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP9—liver cancer	1.11e-05	7.05e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	1.1e-05	7.02e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MYC—liver cancer	1.1e-05	7.02e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TGFB1—liver cancer	1.1e-05	7e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARG—liver cancer	1.1e-05	6.97e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HRAS—liver cancer	1.08e-05	6.88e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK8—liver cancer	1.08e-05	6.86e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AKT1—liver cancer	1.07e-05	6.84e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	1.06e-05	6.76e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	1.05e-05	6.69e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CASP3—liver cancer	1.04e-05	6.63e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL2—liver cancer	1.04e-05	6.62e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6—liver cancer	1.03e-05	6.58e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTP1—liver cancer	1.03e-05	6.52e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KRAS—liver cancer	1.02e-05	6.48e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCND1—liver cancer	1.01e-05	6.45e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—JUN—liver cancer	1.01e-05	6.44e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMOX1—liver cancer	1.01e-05	6.43e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	1e-05	6.39e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CD—liver cancer	9.98e-06	6.35e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—liver cancer	9.95e-06	6.33e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALB—liver cancer	9.85e-06	6.27e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—STAT3—liver cancer	9.85e-06	6.27e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP9—liver cancer	9.84e-06	6.26e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	9.8e-06	6.24e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK8—liver cancer	9.57e-06	6.09e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AKT1—liver cancer	9.54e-06	6.07e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTM1—liver cancer	9.42e-06	5.99e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CA—liver cancer	9.36e-06	5.96e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MYC—liver cancer	9.15e-06	5.82e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TGFB1—liver cancer	9.13e-06	5.81e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TP53—liver cancer	9.06e-06	5.76e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP1A1—liver cancer	8.93e-06	5.68e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—liver cancer	8.84e-06	5.62e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—STAT3—liver cancer	8.75e-06	5.57e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CB—liver cancer	8.7e-06	5.53e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HRAS—liver cancer	8.66e-06	5.51e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KRAS—liver cancer	8.46e-06	5.38e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MTHFR—liver cancer	8.32e-06	5.3e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6—liver cancer	8.29e-06	5.27e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARA—liver cancer	8.17e-06	5.2e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MYC—liver cancer	8.13e-06	5.17e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFB1—liver cancer	8.11e-06	5.16e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	7.77e-06	4.94e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKT1—liver cancer	7.65e-06	4.87e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TP53—liver cancer	7.52e-06	4.78e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KRAS—liver cancer	7.51e-06	4.78e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HRAS—liver cancer	7.19e-06	4.57e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CG—liver cancer	6.99e-06	4.45e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	6.9e-06	4.39e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6—liver cancer	6.88e-06	4.38e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARG—liver cancer	6.75e-06	4.3e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TP53—liver cancer	6.68e-06	4.25e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HRAS—liver cancer	6.39e-06	4.06e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT1—liver cancer	6.35e-06	4.04e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CD—liver cancer	6.15e-06	3.91e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6—liver cancer	6.11e-06	3.89e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALB—liver cancer	6.07e-06	3.86e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT1—liver cancer	5.64e-06	3.59e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CB—liver cancer	5.36e-06	3.41e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CA—liver cancer	5.3e-06	3.37e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKT1—liver cancer	4.33e-06	2.76e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CA—liver cancer	3.27e-06	2.08e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKT1—liver cancer	2.67e-06	1.7e-05	CbGpPWpGaD
